A complete account of the Abrona process — from the initial ingredient brief to the closed batch archive. The methodology is not a quality claim; it is a documented set of procedures that each Abrona production cycle must satisfy before a lot is released.
Every Abrona formulation begins with a written ingredient brief — a document that establishes the target elemental profile, the rationale for each mineral and vitamin's presence, the minimum acceptable purity range, and the list of approved supplier categories. The brief is reviewed by two members of the formulation team before any sourcing activity begins.
Ingredient profiles in Abrona supplements are selected based on published nutritional research. The brief references the relevant published findings for each nutrient included and documents why the chosen form (e.g., bisglycinate over oxide for magnesium) was selected over alternatives. This brief is the permanent first entry in the batch record and is never modified after sourcing approval.
Active ingredients are sourced from documented suppliers, with each batch accompanied by a certificate of composition. Before any supplier is added to the Abrona registry, the sourcing coordinator conducts a facility review — either in-person for regional suppliers within Indonesia, or by documented remote audit for international partners.
Sourcing prioritises suppliers whose facilities maintain food-grade processing standards. The review covers processing hygiene standards, storage conditions, traceability records, and prior certificate history. Approved suppliers are added to the registry with a facility profile, first-contact date, and review revision number. The registry is the permanent reference against which all ingredient orders are checked.
The Abrona lot coding system uses a structured format: ABR-[FORMULATION CODE]-[YEAR]-[QUARTER]-[SEQUENCE]. The lot code is assigned at the point of ingredient receipt confirmation and does not change through production. It is the primary key across the batch record, the production log, the verification certificate, and the archive entry.
The ingredient ratios established in the brief are the sole reference for production blending. Abrona uses a granulation step for all powder-matrix formulations to ensure consistent distribution of active minerals and vitamins within each capsule fill. The granulation parameters — particle size range, moisture target, blend time — are recorded as part of the production log.
Capsule shell selection uses food-grade gelatin for all current Abrona formulations. Shell dimensions and fill weight are logged against the lot code. The finished capsule containers are labelled with the lot number, the serving composition, and the full ingredient list before being sealed for transfer to the third-party verification facility.
A sealed sample from each production batch is submitted to an independent third-party laboratory in Jakarta. The laboratory performs elemental concentration analysis and dissolution profile assessment. Results are returned as a formal certificate — not an internal report — issued under the laboratory's own letterhead and signed by the responsible analyst.
Ingredient profiles undergo independent batch verification for quality and labelling accuracy. The tolerance window accepted by Abrona is tighter than the regulatory minimum. Any batch whose analysis falls outside the accepted tolerance is not released — the lot code is closed, the batch is quarantined, and a new production cycle is initiated. This has occurred twice in the studio's production history, both times in 2020 during early process calibration.
When the third-party certificate confirms that the batch is within the accepted tolerance window, the batch documentation officer closes the lot record. The close entry includes: the certificate reference number, the release date, the responsible signatory, and a revision stamp. After closing, the lot record cannot be modified — entries may be appended, but the base record is immutable.
The lot is released to distribution. The archive entry is retained for five years from the release date. Any consumer holding an Abrona container can request the batch certificate by submitting the lot number to [email protected]. The corresponding certificate is provided within five working days. The archive currently spans seven years of production history.
The Abrona supplier registry currently lists eleven facilities. Each entry records the facility name, location, the date of initial approval, the scope of approved ingredients, and the revision number of the most recent review. New suppliers are not used for production until their registry entry is complete and signed by the sourcing coordinator.
Each supplier in the Abrona registry is subject to an annual review. The review assesses whether the facility's food-grade processing standards remain current, whether any change in ingredient specification has occurred, and whether the prior certificate of composition still accurately represents what the supplier is delivering.
When a review is completed, the registry entry is updated with a new revision number and date. If the review identifies a material change in the supplier's specification, the formulation team is notified and the affected ingredient brief is reviewed before the next production cycle begins. Suppliers who fail the annual review are suspended from the registry pending resolution.
The Abrona origin map records the production or processing region for each active ingredient in the current range. Regional sourcing is prioritised where food-grade supplier options exist within Indonesia. For ingredients where no approved domestic supplier meets the registry criteria, international partners are used — all subject to the same approval process as domestic facilities. The origin map is updated with each new supplier entry and each production lot record.
Several Abrona ingredients — notably the CoQ10 ubiquinone and the vitamin D3 lanolin extract — require controlled-temperature handling during transit. Each cold-chain shipment is accompanied by a temperature log from the supplier facility to the Abrona intake area. The log is filed with the ingredient receipt confirmation and cross-referenced against the lot record. Any shipment that shows a temperature excursion outside the specified range is quarantined and not used in production until the supplier issues a new certificate confirming the ingredient specification has not been compromised.
The independent laboratory performs elemental concentration analysis using an established analytical method for food-supplement samples. The analysis covers all active mineral and vitamin components listed on the label. Results are returned as a quantified concentration value for each element, not a pass/fail summary.
The acceptable variance between the labelled quantity and the measured batch quantity is held to a tighter standard than the Indonesian food-supplement regulatory minimum. This means the label quantity is a conservative statement of what the batch contains — not a ceiling. Batches outside tolerance are not released.
Each certificate is issued by the independent laboratory on its own letterhead, references the Abrona lot number, and is signed by the responsible analyst. Abrona does not alter, reformat, or summarise the certificate — the document filed in the archive is a direct copy of the laboratory's original issue.
Any Abrona consumer can request the batch certificate for a container they hold. Submit the lot number printed on the container label to [email protected]. The certificate will be provided within five working days. Lot records are retained for five years from the release date.
Abrona products are nutritional food-supplements registered with the applicable local regulatory authority under food-supplement classification. Products meet compositional and labelling requirements for nutritional supplement categories.
The food-supplement classification means Abrona products are produced, labelled, and distributed as nutritional provisions. The ingredient brief, the batch record, and the labelling are all produced within this classification framework.
We recommend speaking with a qualified wellness or nutrition professional before introducing any supplement to your daily routine, particularly if you have specific dietary requirements. The Abrona formulation team is not qualified to provide individual nutrition guidance — enquiries about batch records, ingredient sourcing, and formulation composition are handled through the contact page.
Additional questions can be submitted via the contact form. Process-related questions are answered within three working days.
Every production batch — regardless of formulation — undergoes independent third-party analysis before release. Abrona operates on a quarterly batch cycle, meaning each formulation is verified four times per year at minimum. There is no carry-forward: a prior certificate does not cover a subsequent batch.
The lot is quarantined. The batch record is closed with a non-release notation, and the lot number is retired — it will not appear in distribution. The formulation team initiates a root-cause review, which covers both the production process and the supplier certificate for the relevant ingredient. A new production cycle begins only after the root cause is identified and corrected. This process has occurred twice in the studio's history, both in early 2020.
A summary of the ingredient brief — covering the rationale for each nutrient's inclusion and the form selected — is available on request. The full brief (including supplier registry references) is an internal document and is not distributed. Requests for summaries should be directed to [email protected] with the formulation code (e.g., ABR-F01) in the subject line.
Production blending and encapsulation is carried out at a food-grade partner facility in Jakarta, operating under a formal production agreement that requires compliance with the Abrona batch documentation protocol. The formulation team is present during each production run. The Abrona sourcing and batch documentation roles remain in-house — the partner facility does not have access to the supplier registry or the archive system.
The Abrona verification laboratory is selected on the basis of accreditation status, method capability for the specific elemental analysis required, and independence from any Abrona supplier relationship. The current laboratory partner has been in place since the first verification batch in 2020. Its selection is reviewed every two years as part of the studio's audit calendar. The laboratory name and accreditation details are available upon written request.